 |
|
Study: No effects of type II diabetes on aggressiveness of prostate cancer; long-term survival worse
October 17, 2005DENVER- Researchers at Fox Chase Cancer Center found no effects of type II diabetes on aggressiveness of prostate cancer but found that long-term survival is worse. The findings were presented today at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Denver, Colo.
Previous research suggests that insulin may spur the growth of prostate cancer cells. In type II diabetes, the body fails to properly use insulin, which can lead to an excessive amount of insulin in the blood.
"We looked at several key pretreatment factors used to stage the prostate cancer," explained Khanh H. Nguyen, M.D., lead author of the Fox Chase study and a resident in the radiation oncology department at Fox Chase. "These factors include the initial PSA, Gleason score and T-stage. The men with type II diabetes didn't have a significantly different initial profile for their prostate cancer than the men without diabetes. Additionally, type II diabetes did not appear to influence the rates of PSA failures or distant metastases. However, men with type II diabetes had significantly worse long-term overall survival."
The patient cohort for this study included 1,512 men with localized prostate cancer treated with radiation therapy between April 1989 and October 2001. Of these, 1,306 men had no history of type II diabetes (NDM) while 206 men had diabetes (DM-II), which was managed with diet, exercise or medications other than insulin.
The study did not detect significant differences in the initial PSA, Gleason score, or T-stage between the men with and without diabetes. The median initial PSA for men with NDM was 8.2 compared to 8.7 for men with DM-II. Twenty-eight percent of NDM cases versus 26 percent of those with DM-II had a Gleason score of 7-10. By T-stage, 94 percent of NDM patients and 93 percent of DM-II patients had stage T1a-2c disease.
The researchers also looked at the effect of DM-II on long-term radiation treatment outcomes. At 5 years, 27.2 percent (355) of men with NDM had PSA failures versus 23.8 percent (49) of men with DM-II. Seven percent (92) of NDM patients had distant metastases compared to 4.9 percent (10) with DM-II
. Of the patients with NDM, 3.1 percent (41) died of prostate cancer versus 2.4 percent (5) of patient with DM-II. "Although men with type II diabetes did not have significantly different treatment outcomes, having the disease had a detrimental effect on overall survival," said Nguyen.
Of the men without diabetes, 19.1 percent (250) died from all causes, compared to 22.8 percent (47) deaths overall for those with DM-II. This result was statistically significant even after adjusting for the key pretreatment factors.
Nguyen, now a radiation oncologist at the University of Tennessee Medical Center in Knoxville, Tenn., concluded, "The degree of hyperinsulinemia in type II diabetes can vary considerably and may obscure the true impact of insulin on the natural history of prostate cancer. Despite laboratory and epidemiological data suggesting an effect of insulin on prostate cancer growth, in our patient cohort, diabetes did not appear to influence the aggressiveness of prostate cancer at presentation.
"However, type II diabetes conferred a significantly higher overall mortality. Aggressive management of diabetes with diet, exercise, and medications may improve the survival of cancer patients.\\\
Fox Chase Cancer Center
The patient cohort for this study included 1,512 men with localized prostate cancer treated with radiation therapy between April 1989 and October 2001. Of these, 1,306 men had no history of type II diabetes (NDM) while 206 men had diabetes (DM-II), which was managed with diet, exercise or medications other than insulin.
The study did not detect significant differences in the initial PSA, Gleason score, or T-stage between the men with and without diabetes. The median initial PSA for men with NDM was 8.2 compared to 8.7 for men with DM-II. Twenty-eight percent of NDM cases versus 26 percent of those with DM-II had a Gleason score of 7-10. By T-stage, 94 percent of NDM patients and 93 percent of DM-II patients had stage T1a-2c disease.
The researchers also looked at the effect of DM-II on long-term radiation treatment outcomes. At 5 years, 27.2 percent (355) of men with NDM had PSA failures versus 23.8 percent (49) of men with DM-II. Seven percent (92) of NDM patients had distant metastases compared to 4.9 percent (10) with DM-II
. Of the patients with NDM, 3.1 percent (41) died of prostate cancer versus 2.4 percent (5) of patient with DM-II. "Although men with type II diabetes did not have significantly different treatment outcomes, having the disease had a detrimental effect on overall survival," said Nguyen.
Of the men without diabetes, 19.1 percent (250) died from all causes, compared to 22.8 percent (47) deaths overall for those with DM-II. This result was statistically significant even after adjusting for the key pretreatment factors.
Nguyen, now a radiation oncologist at the University of Tennessee Medical Center in Knoxville, Tenn., concluded, "The degree of hyperinsulinemia in type II diabetes can vary considerably and may obscure the true impact of insulin on the natural history of prostate cancer. Despite laboratory and epidemiological data suggesting an effect of insulin on prostate cancer growth, in our patient cohort, diabetes did not appear to influence the aggressiveness of prostate cancer at presentation.
"However, type II diabetes conferred a significantly higher overall mortality. Aggressive management of diabetes with diet, exercise, and medications may improve the survival of cancer patients.\\\
Fox Chase Cancer Center
Type Ii Diabetes Current Events and Type Ii Diabetes News RSSCommon herbicides and fibrates block nutrient-sensing receptor found in gut and pancreas
According to new research from the Monell Center and the Mount Sinai School of Medicine, certain common herbicides and lipid-lowering fibrate drugs act in humans to block T1R3, a nutrient-sensing taste receptor also present in intestine and pancreas.
Prion study reveals first direct information about the protein's molecular structure
A collaboration between scientists at Vanderbilt University and the University of California, San Francisco has led to the first direct information about the molecular structure of prions.
Mechanism related to the onset of various genetic diseases revealed
Researchers at the Department of Biochemistry and Molecular Biology of Universitat Autònoma de Barcelona (UAB) have revealed the process by which proteins with a tendency to cause conformational diseases such as amyotrophic lateral sclerosis, familial amyloidotic polyneuropathy, familial amyloidotic cardiomyopathy, etc. finally end up causing them.
Dartmouth researchers get personal with genetics
Two recent studies by Dartmouth researchers use individual genetic data to reveal the powers and limits of our current understanding of how the genome influences human health and what genes can reveal about the ancestry of the people of New Hampshire.
Changes to DNA linked to diabetes
Genes that regulate the energy consumption of cells have a different structure and expression in type II diabetics than they do in healthy people, according to a new study from the Swedish medical university Karolinska Institutet published in Cell Metabolism.
More obesity blues
Obesity is on a rampage, with the World Health Organization pegging the numbers at more than 300 million worldwide, with a billion more overweight.
Pancreatic cancer risk decreased by one anti-diabetic therapy, increased by others
The antidiabetic medication metformin is associated with a reduced risk of pancreatic cancer in diabetics, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
Starve a Fever, Feed a Cold, Don't Be Stressed
Whether it's getting a cold during exam time or feeling run-down after a big meeting, we've all experienced feeling sick following a particularly stressful time at work or school. Is this merely coincidence, or is it possible that stress can actually make us sick?
Researchers find that eating high levels of fructose impairs memory in rats
Researchers at Georgia State University have found that diets high in fructose - a type of sugar found in most processed foods and beverages - impaired the spatial memory of adult rats.
Joint replacement patients with diabetes greatly benefit from controlled glucose
Diabetics undergoing total joint replacement often are at a higher risk of experiencing complications after surgery due to various pre-existing health conditions.
More Type Ii Diabetes Current Events and Type Ii Diabetes News Articles
 |
The Other Diabetes: Living and Eating Well with Type 2 Diabetes by Elizabeth N. Hiser (Author) Our national epidemic of type 2 diabetes, obesity, and heart disease is the price we pay for a diet that is too rich for our modern lifestyle. To fight back, we have focused on eating low-fat foods and quick-fix diets that just don't seem to work. The Other Diabetes, a consumer guide to type 2 diabetes, can help you change all that with the optimal eating plan. The Good Fat Diet offers a collection of eighty healthy and wholesome recipes. |
 |
The First Year: Type 2 Diabetes: An Essential Guide for the Newly Diagnosed (First Year, The) by Gretchen Becker (Author), Allison B. Goldfine (Foreword) After Gretchen Becker was diagnosed with type 2 diabetes in 1996, she educated herself on every aspect of this chronic condition — by reading medical and scientific books and journals, talking with doctors and listening to her own body. In 2001, she marshaled everything she had learned as a "patient-expert" into the first edition of this book, which she has now completely updated and revised. The First Year®—Type 2 Diabetes uniquely guides you step-by-step through your first year with diabetes, walking you through everything you need to learn and do each day of your first week after diagnosis, each subsequent week of the first month, and each subsequent month of the crucial first year. In clear, concise, accessible language, Becker covers a wide range of practical, medical, and... |
 |
The Type II Diabetes Diet Book by Calvin Ezrin (Author), Robert Kowalski (Author) Proved to be remarkably effective for both Type II diabetics and nondiabetic people with chronic weight problems, the Insulin Control Diet--based on low-carbohydrate and low-caloric intake--allows patients to decrease insulin production and convert stored fat into fuel. In this new edition, Dr. Calvin Ezrin provides updated ADA recommendations and a complete section of revised recipes and meal plans. |
 |
The Good News Eating Plan for Type II Diabetes by Elaine Magee (Author) An easy-to-follow, personalized eating plan —loaded with the foods you really want! At last, a book that can help you eat better, stay healthier, and enjoy the foods you love-written by a registered dietitian and bestselling nutrition author. The Good News Eating Plan for Type II Diabetes considers your personal dietary and lifestyle preferences as it provides the tools you need to start making choices that are right for you. Here is delicious proof positive that it's possible to eat well and stay within the American Diabetes Association's new guidelines. Elaine Magee's nutritionally sound strategies for sensible blood sugar management and weight control will help you create a practical eating plan that will not leave you feeling deprived of your favorite foods. Packed... |
 |
Weight Management for Type II Diabetes: An Action Plan by Jackie Labat (Author), Annette Maggi (Author) Take control of your weight—and your diabetes. Managing your weight is critical when you have diabetes. In fact, losing as little as 10 to 20 pounds can improve diabetes control. With this innovative book, you can manage your weight and your diabetes by making gradual lifestyle changes you’ll be able to live with for the rest of your life—like following a low-fat meal plan, becoming more active, and managing stress. Weight Management for Type II Diabetes will help you assess habits, teach you techniques of behavior change, and motivate you to find the support you need to manage both diabetes and your weight. This interactive guide takes you through the steps of developing a personalized plan that considers your lifestyle, personality, family situation, and wants and needs. Authors... |
 |
New Treatments for People with Type II Diabetes: (Home Use) Part of the award winning public television series Healthy Body/Healthy Mind. With more than a million people diagnosed every year with type II diabetes in the United States you might think there are standard treatments that work just about the same way for nearly everyone. But as you'll see in this program the treatments available for people with Type II Diabetes work differently with each patient and depend largely on the patient's specific needs. You'll also see how important it is that type II diabetes be effectively managed in patients over the long haul and we'll have solid information on how people with type II diabetes can achieve that long-term management goal. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will... |
|
New Treatments For People With Type Ii Diabetes: Directed By: Information Television Network | |
|
Healthy Ways, Healthy Days - An Easy Walking Program for People with Type II Diabetes Also With: Carol Greenberg (Primary Contributor), Upjohn (Producer) | |
|
Type II (Diabetes) by Brick Casey | |
 |
Type II (Diabetes) Brick Casey (Primary Contributor) |
| © 2009 BrightSurf.com |